share_log

4: Statement of changes in beneficial ownership of securities-Director XU CHERYL

4: Statement of changes in beneficial ownership of securities-Director XU CHERYL

4:持股变动声明-董事 XU CHERYL
美股SEC公告 ·  05/21 20:25
Moomoo AI 已提取核心信息
Cheryl Xu, associated with 60 Degrees Pharmaceuticals, completed a purchase of 2,000 shares of common stock on May 16, 2024. The transaction was executed at a price of $0.223 per share, resulting in a total investment of $446. Following the action, Xu's direct holdings in the company increased to 228,934 shares. The transaction is classified as an exercise or conversion of derivative security, according to the transaction code description.
Cheryl Xu, associated with 60 Degrees Pharmaceuticals, completed a purchase of 2,000 shares of common stock on May 16, 2024. The transaction was executed at a price of $0.223 per share, resulting in a total investment of $446. Following the action, Xu's direct holdings in the company increased to 228,934 shares. The transaction is classified as an exercise or conversion of derivative security, according to the transaction code description.
与60度制药有联系的谢丽尔·徐于2024年5月16日完成了对2,000股普通股的收购。该交易以每股0.223美元的价格执行,总投资额为446美元。行动后,徐在公司的直接持股量增加到228,934股。根据交易代码的描述,该交易被归类为衍生证券的行使或转换。
与60度制药有联系的谢丽尔·徐于2024年5月16日完成了对2,000股普通股的收购。该交易以每股0.223美元的价格执行,总投资额为446美元。行动后,徐在公司的直接持股量增加到228,934股。根据交易代码的描述,该交易被归类为衍生证券的行使或转换。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息